These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 11681710)
1. In vivo effects of vanadium in diabetic rats are independent of changes in PI-3 kinase activity in skeletal muscle. Mohammad A; Bhanot S; McNeill JH Mol Cell Biochem; 2001 Jul; 223(1-2):103-8. PubMed ID: 11681710 [TBL] [Abstract][Full Text] [Related]
2. In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats. Marzban L; Bhanot S; McNeill JH Mol Cell Biochem; 2001 Jul; 223(1-2):147-57. PubMed ID: 11681716 [TBL] [Abstract][Full Text] [Related]
3. Effects of bis(maltolato) oxovanadium (IV) on protein serine kinases in skeletal muscle of streptozotocin-diabetic rats. Bhanot S; Girn J; Poucheret P; McNeill JH Mol Cell Biochem; 1999 Dec; 202(1-2):131-40. PubMed ID: 10706003 [TBL] [Abstract][Full Text] [Related]
4. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats. Winter CL; Lange JS; Davis MG; Gerwe GS; Downs TR; Peters KG; Kasibhatla B Exp Biol Med (Maywood); 2005 Mar; 230(3):207-16. PubMed ID: 15734724 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Yuen VG; Orvig C; McNeill JH Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453 [TBL] [Abstract][Full Text] [Related]
6. Bis(maltolato)oxovanadium(IV) inhibits the activity of PTP1B in Zucker rat skeletal muscle in vivo. Mohammad A; Wang J; McNeill JH Mol Cell Biochem; 2002 Jan; 229(1-2):125-8. PubMed ID: 11936837 [TBL] [Abstract][Full Text] [Related]
7. Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV). Yuen VG; Orvig C; McNeill JH Can J Physiol Pharmacol; 1993; 71(3-4):263-9. PubMed ID: 8402390 [TBL] [Abstract][Full Text] [Related]
8. Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty (ZDF) rats. Yuen VG; Vera E; Battell ML; Li WM; McNeill JH Diabetes Res Clin Pract; 1999 Jan; 43(1):9-19. PubMed ID: 10199584 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo. Marzban L; Rahimian R; Brownsey RW; McNeill JH Endocrinology; 2002 Dec; 143(12):4636-45. PubMed ID: 12446591 [TBL] [Abstract][Full Text] [Related]
10. Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats. Yuen VG; Orvig C; McNeill JH Am J Physiol; 1997 Jan; 272(1 Pt 1):E30-5. PubMed ID: 9038848 [TBL] [Abstract][Full Text] [Related]
11. Effect of vanadium on insulin sensitivity and appetite. Wang J; Yuen VG; McNeill JH Metabolism; 2001 Jun; 50(6):667-73. PubMed ID: 11398143 [TBL] [Abstract][Full Text] [Related]
12. Vanadium increases GLUT4 in diabetic rat skeletal muscle. Mohammad A; Sharma V; McNeill JH Mol Cell Biochem; 2002 Apr; 233(1-2):139-43. PubMed ID: 12083368 [TBL] [Abstract][Full Text] [Related]
13. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV). Yuen VG; Orvig C; Thompson KH; McNeill JH Can J Physiol Pharmacol; 1993; 71(3-4):270-6. PubMed ID: 8402391 [TBL] [Abstract][Full Text] [Related]
14. In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats. Li SH; McNeill JH Mol Cell Biochem; 2001 Jan; 217(1-2):121-9. PubMed ID: 11269655 [TBL] [Abstract][Full Text] [Related]
15. Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes. Shinde UA; Mehta AA; Goyal RK Indian J Exp Biol; 2001 Sep; 39(9):864-70. PubMed ID: 11831366 [TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle mitogen-activated protein kinases and ribosomal S6 kinases. Suppression in chronic diabetic rats and reversal by vanadium. Hei YJ; Chen X; Pelech SL; Diamond J; McNeill JH Diabetes; 1995 Oct; 44(10):1147-55. PubMed ID: 7556949 [TBL] [Abstract][Full Text] [Related]
17. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds. Wasan KM; Risovic V; Yuen VG; McNeill JH J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173 [TBL] [Abstract][Full Text] [Related]
18. Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent. Sánchez-González C; López-Chaves C; Trenzado CE; Aranda P; López-Jurado M; Gómez-Aracena J; Montes-Bayón M; Sanz-Medel A; Llopis J ScientificWorldJournal; 2014; 2014():706074. PubMed ID: 24511298 [TBL] [Abstract][Full Text] [Related]
19. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats. Cam MC; Brownsey RW; Rodrigues B; McNeill JH Metabolism; 2001 Jun; 50(6):674-80. PubMed ID: 11398144 [TBL] [Abstract][Full Text] [Related]
20. Bis(maltolato)oxovanadium(IV) (BMOV) Attenuates Apoptosis in High Glucose-Treated Cardiac Cells and Diabetic Rat Hearts by Regulating the Unfolded Protein Responses (UPRs). Cong XQ; Piao MH; Li Y; Xie L; Liu Y Biol Trace Elem Res; 2016 Oct; 173(2):390-8. PubMed ID: 26983714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]